Aveanna Healthcare (NASDAQ:AVAH) Price Target Increased to $5.00 by Analysts at Royal Bank of Canada

Aveanna Healthcare (NASDAQ:AVAH) had its price objective boosted by analysts at Royal Bank of Canada from $3.00 to $5.00 in a report released on Friday, Benzinga reports. The brokerage presently has a “sector perform” rating on the stock. Royal Bank of Canada’s target price suggests a potential upside of 3.73% from the stock’s previous close.

Other equities research analysts also recently issued research reports about the company. Deutsche Bank Aktiengesellschaft raised their price target on Aveanna Healthcare from $3.00 to $5.00 and gave the company a “buy” rating in a report on Friday. UBS Group increased their price target on shares of Aveanna Healthcare from $1.70 to $2.80 and gave the company a “sell” rating in a report on Friday. Three analysts have rated the stock with a sell rating, one has assigned a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $3.45.

Aveanna Healthcare Trading Up 6.4 %

Shares of Aveanna Healthcare stock traded up $0.29 during trading on Friday, reaching $4.82. The stock had a trading volume of 751,608 shares, compared to its average volume of 137,107. The company has a market capitalization of $927.27 million, a price-to-earnings ratio of -8.02 and a beta of 2.08. Aveanna Healthcare has a 52 week low of $0.85 and a 52 week high of $5.06. The stock has a fifty day moving average price of $3.11 and a two-hundred day moving average price of $2.67.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings results on Thursday, May 9th. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.01. The company had revenue of $490.65 million for the quarter, compared to analyst estimates of $485.05 million. During the same period last year, the firm earned ($0.06) EPS. On average, equities analysts forecast that Aveanna Healthcare will post -0.13 EPS for the current fiscal year.

Institutional Investors Weigh In On Aveanna Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. SG Americas Securities LLC increased its stake in Aveanna Healthcare by 24.6% during the 4th quarter. SG Americas Securities LLC now owns 23,941 shares of the company’s stock worth $64,000 after acquiring an additional 4,721 shares during the period. Acadian Asset Management LLC increased its position in shares of Aveanna Healthcare by 185.6% in the first quarter. Acadian Asset Management LLC now owns 29,385 shares of the company’s stock worth $72,000 after purchasing an additional 19,096 shares during the period. Bank of New York Mellon Corp raised its stake in Aveanna Healthcare by 6.6% in the second quarter. Bank of New York Mellon Corp now owns 149,761 shares of the company’s stock valued at $413,000 after purchasing an additional 9,243 shares in the last quarter. Vanguard Group Inc. raised its position in Aveanna Healthcare by 1.8% during the first quarter. Vanguard Group Inc. now owns 2,571,251 shares of the company’s stock valued at $6,402,000 after purchasing an additional 44,970 shares in the last quarter. Finally, King Street Capital Management L.P. lifted its stake in Aveanna Healthcare by 50.6% during the fourth quarter. King Street Capital Management L.P. now owns 6,400,000 shares of the company’s stock worth $17,152,000 after purchasing an additional 2,150,000 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.